Enlivex
enlivex.com
Actively hiring
Financial Services
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Enlivex Posts Massive H1 2026 Profit on Surging Digital Asset Holdings
Detailed price information for Enlivex Ltd (ENLV-Q) from The Globe and Mail including charting and trades.
Read more
Report
Enlivex Therapeutics stock reports cancelled financing
Enlivex Therapeutics stock stood at USD 0.64 on September 23, 2026, 97.64 percent below its 52-week high. The company ended a 66,666,667-share RAIN deal.
Read more
Report
Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement
Tipranks Press Release.
Read more
Report
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) (
Read more
Report
Enlivex Ltd.: Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
- As of July 18, 2026, net asset value (NAV1) per share was $66.16 - As of July 18, 2026, Enlivex held 79,550,593,122 RAIN tokens with a total value of approximately $1.1 billion2- Nes-Ziona, Israel
Read more
Report
Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis
Oren Hershkovitz, CEO, commented," Complementing our ongoing clinical trial in osteoarthritis, which is a low-grade chronic inflammatory joint disease, this new study provides an opportunity to assess Allocetra in a high-grade inflammatory joint disease s
Read more
Report
Enlivex Announces Issuance of European Patent Covering the Use of Allocetra to Prevent Cytokine Release Syndrome (CRS) Resulting from CAR T-Cell Therapy
Nes-Ziona, Israel, May 08, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the
Read more
Report
Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
This month, Enlivex Therapeutics Ltd. (NASDAQ:ENLV) announced a new clinical collaboration agreement with Beigene Ltd to test a new combination treatment to fight advanced-stage solid tumors.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Ness Ziona
Israel
HQ
50-200 est. staff
14 Einstein Street, Ness Ziona, 7403618, IL